Genome analysis identifies the p15ink4b tumor suppressor as a direct target of the ZNF217/CoREST complex

Molecular and Cellular Biology

Volumn 28, Issue 19, 2008, Pages 6066-6077

  Thillainadesan, Gobi ^a   Isovic, Majdina ^a   Loney, Esther ^a   Andrews, Joseph ^a   Tini, Marc ^a   Torchia, Joseph ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON REGIONAL CANCER PROGRAM   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TUBULIN; CARBOXY TERMINAL BINDING PROTEIN 1; CARBOXY TERMINAL BINDING PROTEIN 2; CONNEXIN 47; CYCLIN DEPENDENT KINASE INHIBITOR 2B; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; LYSINE DEMETHYLASE 1; MICROTUBULE ASSOCIATED PROTEIN 2; NOTCH1 RECEPTOR; ONCOPROTEIN; PROTEIN ABCA12; PROTEIN AKRIC3; PROTEIN CDC25C; PROTEIN COREST; PROTEIN EFNB2; PROTEIN EHF; PROTEIN INK4B; PROTEIN MCM8; PROTEIN RAC3; PROTEIN SF3A1; PROTEIN VAV3; PROTEIN ZNF217; SMAD2 PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VAV PROTEIN;

ACETYLATION; ARTICLE; BREAST CANCER; CELL STRAIN MCF 7; CHROMATIN IMMUNOPRECIPITATION; COMPLEX FORMATION; CONTROLLED STUDY; DOWN REGULATION; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENOME ANALYSIS; HUMAN; HUMAN CELL; METHYLATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; UNINDEXED SEQUENCE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P15; DNA-BINDING PROTEINS; GENOMICS; HUMANS; NERVE TISSUE PROTEINS; PROMOTER REGIONS (GENETICS); REPRESSOR PROTEINS; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 52649146398     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00246-08     Document Type: Article

References (54)

1. Agalioti, T., G. Chen, and D. Thanos. 2002. Deciphering the transcriptional histone acetylation code for a human gene. Cell 111:381-392.
2. Bar-Shira, A., J. H. Pinthus, U. Rozovsky, M. Goldstein, W. R. Sellers, Y. Yaron, Z. Eshhar, and A. Orr-Urtreger. 2002. Multiple genes in human 20q13 chromosomal region are involved in an advanced prostate cancer xenograft. Cancer Res. 62:6803-6807.
3. Baylin, S. B., and J. E. Ohm. 2006. Epigenetic gene silencing in cancer: a mechanism for early oncogenic pathway addiction? Nat. Rev. Cancer 6:107-116.
4. Berger, S. L. 2007. The complex language of chromatin regulation during transcription. Nature 447:407-412.
5. Bolstad, B. M., R. A. Irizarry, M. Astrand, and T. P. Speed. 2003. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19:185-193.
6. Bracken, A. P., N. Dietrich, D. Pasini, K. H. Hansen, and K. Helin. 2006. Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev. 20:1123-1136.
7. Carroll, J. S., C. A. Meyer, J. Song, W. Li, T. R. Geistlinger, J. Eeckhoute, A. S. Brodsky, E. K. Keeton, K. C. Fertuck, G. F. Hall, Q. Wang, S. Bekiranov, V. Sementchenko, E. A. Fox, P. A. Silver, T. R. Gingeras, X. S. Liu, and M. Brown. 2006. Genome-wide analysis of estrogen receptor binding sites. Nat. Genet. 38:1289-1297.
8. Cawley, S., S. Bekiranov, H. H. Ng, P. Kapranov, E. A. Sekinger, D. Kampa, A. Piccolboni, V. Sementchenko, J. Cheng, A. J. Williams, R. Wheeler, B. Wong, J. Drenkow, M. Yamanaka, S. Patel, S. Brubaker, H. Tammana, G. Helt, K. Struhl, and T. R. Gingeras. 2004. Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. Cell 116:499-509.
9. Chin, K., C. O. de Solorzano, D. Knowles, A. Jones, W. Chou, E. G. Rodriguez, W. L. Kuo, B. M. Ljung, K. Chew, K. Myambo, M. Miranda, S. Krig, J. Garbe, M. Stampfer, P. Yaswen, J. W. Gray, and S. J. Lockett. 2004. In situ analyses of genome instability in breast cancer. Nat. Genet. 36:984-988.
10. Chin, K., S. DeVries, J. Fridlyand, P. T. Spellman, R. Roydasgupta, W. L. Kuo, A. Lapuk, R. M. Neve, Z. Qian, T. Ryder, F. Chen, H. Feiler, T. Tokuyasu, C. Kingsley, S. Dairkee, Z. Meng, K. Chew, D. Pinkel, A. Jain, B. M. Ljung, L. Esserman, D. G. Albertson, F. M. Waldman, and J. W. Gray. 2006. Genomic and transcriptional aberrations linked to breast cancer pathophysiologics. Cancer Cell 10:529-541.
11. Collins, C., J. M. Rommens, D. Kowbel, T. Godfrey, M. Tanner, S. I. Hwang, D. Polikoff, G. Nonet, J. Cochran, K. Myambo, K. E. Jay, J. Froula, T. Cloutier, W. L. Kuo, P. Yaswen, S. Dairkee, J. Giovanola, G. B. Hutchinson, J. Isola, O. P. Kallioniemi, M. Palazzolo, C. Martin, C. Ericsson, D. Pinkel, and J. W. Gray. 1998. Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma. Proc. Natl. Acad. Sci. USA 95:8703-8708.
12. Cowger, J. J., Q. Zhao, M. Isovic, and J. Torchia. 2007. Biochemical characterization of the zinc-finger protein 217 transcriptional repressor complex: identification of a ZNF217 consensus recognition sequence. Oncogene 26:3378-3386.
13. De Rubertis, F., D. Kadosh, S. Henchoz, D. Pauli, G. Reuter, K. Struhl, and P. Spierer. 1996. The histone deacetylase RPD3 counteracts genomic silencing in Drosophila and yeast. Nature 384:589-591.
14. Ink4B. Mol. Cell 9:133-143.
15. Ink4B transcription in response to TGF-beta. EMBO J. 19:5178-5193.
16. Forneris, F., C. Binda, A. Dall'Aglio, M. W. Fraaije, E. Battaglioli, and A. Mattevi. 2006. A highly specific mechanism of histone H3-K4 recognition by histone demethylase LSD1. J. Biol. Chem. 281:35289-35295.
17. Forneris, F., C. Binda, M. A. Vanoni, E. Battaglioli, and A. Mattevi. 2005. Human histone demethylase LSD1 reads the histone code. J. Biol. Chem. 280:41360-41365.
18. Garcia-Bassets, I., Y. S. Kwon, F. Telese, G. G. Prefontaine, K. R. Hutt, C. S. Cheng, B. G. Ju, K. A. Ohgi, J. Wang, L. Escoubet-Lozach, D. W. Rose, C. K. Glass, X. D. Fu, and M. G. Rosenfeld. 2007. Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors. Cell 128:505-518.
19. Ghiorzo, P., L. Pastorino, L. Bonelli, R. Cusano, A. Nicora, S. Zupo, P. Queirolo, M. Sertoli, V. Pugliese, and G. Bianchi-Scarra. 2004. INK4/ARF germline alterations in pancreatic cancer patients. Ann. Oncol. 15:70-78.
20. Gil, J., and G. Peters. 2006. Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat. Rev. Mol. Cell Biol. 7:667-677.
21. Gomis, R. R., C. Alarcon, W. He, Q. Wang, J. Seoane, A. Lash, and J. Massague. 2006. A FoxO-Smad synexpression group in human keratinocytes. Proc. Natl. Acad. Sci. USA 103:12747-12752.
22. Gomis, R. R., C. Alarcon, C. Nadal, C. Van Poznak, and J. Massague. 2006. C/EBPβ at the core of the TGFβ cytostatic response and its evasion in metastatic breast cancer cells. Cancer Cell 10:203-214.
23. Hakimi, M. A., Y. Dong, W. S. Lane, D. W. Speicher, and R. Shiekhattar. 2003. A candidate X-linked mental retardation gene is a component of a new family of histone deacetylase-containing complexes. J. Biol. Chem. 278: 7234-7239.
24. Harlow, E., and D. Lane. 1999. Using antibodies: a laboratory manual. Cold Spring Harbor Laboraory Press, Cold Spring Harbor, NY.
25. He, J., S. B. Tegen, A. R. Krawitz, G. S. Martin, and K. Luo. 2003. The transforming activity of Ski and SnoN is dependent on their ability to repress the activity of Smad proteins. J. Biol. Chem. 278:30540-30547.
26. Hidaka, S., T. Yasutake, H. Takeshita, M. Kondo, T. Tsuji, A. Nanashima, T. Sawai, H. Yamaguchi, T. Nakagoe, H. Ayabe, and Y. Tagawa. 2000. Differences in 20q13.2 copy number between colorectal cancers with and without liver metastasis. Clin. Cancer Res. 6:2712-2717.
27. Huang, G., S. Krig, D. Kowbel, H. Xu, B. Hyun, S. Volik, B. Feuerstein, G. B. Mills, D. Stokoe, P. Yaswen, and C. Collins. 2005. ZNF217 suppresses cell death associated with chemotherapy and telomere dysfunction. Hum. Mol. Genet. 14:3219-3225.
28. Kim, W. Y., and N. E. Sharpless. 2006. The regulation of INK4/ARF in cancer and aging. Cell 127:265-275.
29. Krig, S. R., V. X. Jin, M. C. Bieda, H. O'Geen, P. Yaswen, R. Green, and P. J. Farnham. 2007. Identification of genes directly regulated by the oncogene ZNF217 using chromatin immunoprecipitation (ChIP)-chip assays. J. Biol. Chem. 282:9703-9712.
30. Kwon, Y. S., I. Garcia-Bassets, K. R. Hutt, C. S. Cheng, M. Jin, D. Liu, C. Benner, D. Wang, Z. Ye, M. Bibikova, J. B. Fan, L. Duan, C. K. Glass, M. G. Rosenfeld, and X. D. Fu. 2007. Sensitive ChIP-DSL technology reveals an extensive estrogen receptor alpha-binding program on human gene promoters. Proc. Natl. Acad. Sci. USA 104:4852-4857.
31. INK4c cell cycle inhibitors in proliferation and tumorigenesis. EMBO J. 19:3496-3506.
32. Lee, M. G., C. Wynder, N. Cooch, and R. Shiekhattar. 2005. An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation. Nature 437:432-435.
33. Li, P., S. Maines-Bandiera, W. L. Kuo, Y. Guan, Y. Sun, M. Hills, G. Huang, C. C. Collins, P. C. K. Leung, J. W. Gray, and N. Auersperg. 2007. Multiple roles of the candidate oncogene ZNF217 in ovarian epithelial neoplastic progression. Int. J. Cancer 120:1863-1873.
34. Luo, K. 2004. Ski and SnoN: negative regulators of TGF-beta signaling. Curr. Opin. Genet. Dev. 14:65-70.
35. Luo, K., S. L. Stroschein, W. Wang, D. Chen, E. Martens, S. Zhou, and Q. Zhou. 1999. The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling. Genes Dev. 13:2196-2206.
36. Reference deleted.
37. Metivier, R., G. Penot, M. R. Hubner, G. Reid, H. Brand, M. Kos, and F. Gannon. 2003. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115:751-763.
38. Metzger, E., M. Wissmann, N. Yin, J. M. Muller, R. Schneider, A. H. Peters, T. Gunther, R. Buettner, and R. Schule. 2005. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 437:436-439.
39. Nonet, G. H., M. R. Stampfer, K. Chin, J. W. Gray, C. C. Collins, and P. Yaswen. 2001. The ZNF217 gene amplified in breast cancers promotes immortalization of human mammary epithelial cells. Cancer Res. 61:1250-1254.
40. Pardali, K., and A. Moustakas. 2007. Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. Biochim. Biophys. Acta 1775:21-62.
41. Quinlan, K. G., M. Nardini, A. Verger, P. Francescato, P. Yaswen, D. Corda, M. Bolognesi, and M. Crossley. 2006. Specific recognition of ZNF217 and other zinc-finger proteins at a surface groove of CtBPs. Mol. Cell Biol. 26:8202-8213.
42. Scacheri, P. C., S. Davis, D. T. Odom, G. E. Crawford, S. Perkins, M. J. Halawi, S. K. Agarwal, S. J. Marx, A. M. Spiegel, P. S. Meltzer, and F. S. Collins. 2006. Genome-wide analysis of menin binding provides insights into MEN1 tumorigenesis. PLoS Genet. 2:e51.
43. INK4b. Nat. Cell Biol. 3:400-408.
44. Shi, Y., F. Lan, C. Matson, P. Mulligan, J. R. Whetstine, P. A. Cole, and R. A. Casero. 2004. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119:941-953.
45. Shi, Y. J., C. Matson, F. Lan, S. Iwase, T. Baba, and Y. Shi. 2005. Regulation of LSD1 histone demethylase activity by its associated factors. Mol. Cell 19:857-864.
46. Sill, H., J. M. Goldman, and N. C. Cross. 1995. Homozygous deletions of the p16 tumor-suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia. Blood 85:2013-2016.
47. INK4b expression by Myc through association with Miz-1. Nat. Cell Biol. 3:392-399.
48. Suzuki, S., K. Egami, K. Sasajima, M. Ghazizadeh, H. Shimizu, H. Watanabe, H. Hasegawa, S. Iida, T. Matsuda, Y. Okihama, M. Hosone, K. Shimizu, O. Kawanami, and T. Tajiri. 2004. Comparative study between DNA copy number aberrations determined by quantitative microsatellite analysis and clinical outcome in patients with stomach cancer. Clin. Cancer Res. 10:3013-3019.
49. Tanner, M. M., S. Grenman, A. Koul, O. Johannsson, P. Meltzer, T. Pejovic, A. Borg, and J. J. Isola. 2000. Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer. Clin. Cancer Res. 6:1833-1839.
50. Ting, A. H., K. M. McGarvey, and S. B. Baylin. 2006. The cancer epigenome: components and functional correlates. Genes Dev. 20:3215-3231.
51. Watanabe, T., I. Imoto, T. Katahira, A. Hirasawa, I. Ishiwata, M. Emi, M. Takayama, A. Sato, and J. Inazawa. 2002. Differentially regulated genes as putative targets of amplifications at 20q in ovarian cancers. Jpn. J. Cancer Res. 93:1114-1122.
52. Weiss, M. M., A. M. Snijders, E. J. Kuipers, B. Ylstra, D. Pinkel, S. G. Meuwissen, P. J. van Diest, D. G. Albertson, and G. A. Meijer. 2003. Determination of amplicon boundaries at 20q13.2 in tissue samples of human gastric adenocarcinomas by high-resolution microarray comparative genomic hybridization. J. Pathol. 200:320-326.
53. Wu, S. Y., A. Y. Lee, S. Y. Hou, J. K. Kemper, H. Erdjument-Bromage, P. Tempst, and C. M. Chiang. 2006. Brd4 links chromatin targeting to HPV transcriptional silencing. Genes Dev. 20:2383-2396.
54. You, A., J. K. Tong, C. M. Grozinger, and S. L. Schreiber. 2001. CoREST is an integral component of the CoREST-human histone deacetylase complex. Proc. Natl. Acad. Sci. USA 98:1454-1458.